{"pmid":32446313,"title":"Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.","text":["Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.","Lancet Respir Med","Elbadawi, Mohamed","Efferth, Thomas","32446313"],"journal":"Lancet Respir Med","authors":["Elbadawi, Mohamed","Efferth, Thomas"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446313","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/S2213-2600(20)30238-1","topics":["Mechanism","Treatment"],"weight":1,"_version_":1667698385952440320,"score":9.490897,"similar":[{"pmid":32332922,"title":"SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2.","text":["SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2.","Nat Rev Nephrol","Allison, Susan J","32332922"],"journal":"Nat Rev Nephrol","authors":["Allison, Susan J"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32332922","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1038/s41581-020-0291-8","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494011965440,"score":59.995697},{"pmid":32405028,"title":"Infection of bat and human intestinal organoids by SARS-CoV-2.","text":["Infection of bat and human intestinal organoids by SARS-CoV-2.","A novel coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-emerged in humans in Wuhan, China, in December 2019 and has since disseminated globally(1,2). As of April 16, 2020, the confirmed case count of coronavirus disease 2019 (COVID-19) had surpassed 2 million. Based on full-genome sequence analysis, SARS-CoV-2 shows high homology to SARS-related coronaviruses identified in horseshoe bats(1,2). Here we show the establishment and characterization of expandable intestinal organoids derived from horseshoe bats of the Rhinolophus sinicus species that can recapitulate bat intestinal epithelium. These bat enteroids are fully susceptible to SARS-CoV-2 infection and sustain robust viral replication. Development of gastrointestinal symptoms in some patients with COVID-19 and detection of viral RNA in fecal specimens suggest that SARS-CoV-2 might cause enteric, in addition to respiratory, infection(3,4). Here we demonstrate active replication of SARS-CoV-2 in human intestinal organoids and isolation of infectious virus from the stool specimen of a patient with diarrheal COVID-19. Collectively, we established the first expandable organoid culture system of bat intestinal epithelium and present evidence that SARS-CoV-2 can infect bat intestinal cells. The robust SARS-CoV-2 replication in human intestinal organoids suggests that the human intestinal tract might be a transmission route of SARS-CoV-2.","Nat Med","Zhou, Jie","Li, Cun","Liu, Xiaojuan","Chiu, Man Chun","Zhao, Xiaoyu","Wang, Dong","Wei, Yuxuan","Lee, Andrew","Zhang, Anna Jinxia","Chu, Hin","Cai, Jian-Piao","Yip, Cyril Chik-Yan","Chan, Ivy Hau-Yee","Wong, Kenneth Kak-Yuen","Tsang, Owen Tak-Yin","Chan, Kwok-Hung","Chan, Jasper Fuk-Woo","To, Kelvin Kai-Wang","Chen, Honglin","Yuen, Kwok Yung","32405028"],"abstract":["A novel coronavirus-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-emerged in humans in Wuhan, China, in December 2019 and has since disseminated globally(1,2). As of April 16, 2020, the confirmed case count of coronavirus disease 2019 (COVID-19) had surpassed 2 million. Based on full-genome sequence analysis, SARS-CoV-2 shows high homology to SARS-related coronaviruses identified in horseshoe bats(1,2). Here we show the establishment and characterization of expandable intestinal organoids derived from horseshoe bats of the Rhinolophus sinicus species that can recapitulate bat intestinal epithelium. These bat enteroids are fully susceptible to SARS-CoV-2 infection and sustain robust viral replication. Development of gastrointestinal symptoms in some patients with COVID-19 and detection of viral RNA in fecal specimens suggest that SARS-CoV-2 might cause enteric, in addition to respiratory, infection(3,4). Here we demonstrate active replication of SARS-CoV-2 in human intestinal organoids and isolation of infectious virus from the stool specimen of a patient with diarrheal COVID-19. Collectively, we established the first expandable organoid culture system of bat intestinal epithelium and present evidence that SARS-CoV-2 can infect bat intestinal cells. The robust SARS-CoV-2 replication in human intestinal organoids suggests that the human intestinal tract might be a transmission route of SARS-CoV-2."],"journal":"Nat Med","authors":["Zhou, Jie","Li, Cun","Liu, Xiaojuan","Chiu, Man Chun","Zhao, Xiaoyu","Wang, Dong","Wei, Yuxuan","Lee, Andrew","Zhang, Anna Jinxia","Chu, Hin","Cai, Jian-Piao","Yip, Cyril Chik-Yan","Chan, Ivy Hau-Yee","Wong, Kenneth Kak-Yuen","Tsang, Owen Tak-Yin","Chan, Kwok-Hung","Chan, Jasper Fuk-Woo","To, Kelvin Kai-Wang","Chen, Honglin","Yuen, Kwok Yung"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405028","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1038/s41591-020-0912-6","locations":["Wuhan","China","horseshoe","Rhinolophus"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1666950579830652928,"score":58.969173},{"pmid":32483314,"title":"COVID-19: organoids go viral.","text":["COVID-19: organoids go viral.","Nat Rev Mol Cell Biol","Clevers, Hans","32483314"],"journal":"Nat Rev Mol Cell Biol","authors":["Clevers, Hans"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32483314","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/s41580-020-0258-4","topics":["Mechanism","Treatment"],"weight":1,"_version_":1668532114764595201,"score":52.979183},{"pmid":32303993,"title":"Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids.","text":["Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids.","Protein Cell","Zhao, Bing","Ni, Chao","Gao, Ran","Wang, Yuyan","Yang, Li","Wei, Jinsong","Lv, Ting","Liang, Jianqing","Zhang, Qisheng","Xu, Wei","Xie, Youhua","Wang, Xiaoyue","Yuan, Zhenghong","Liang, Junbo","Zhang, Rong","Lin, Xinhua","32303993"],"journal":"Protein Cell","authors":["Zhao, Bing","Ni, Chao","Gao, Ran","Wang, Yuyan","Yang, Li","Wei, Jinsong","Lv, Ting","Liang, Jianqing","Zhang, Qisheng","Xu, Wei","Xie, Youhua","Wang, Xiaoyue","Yuan, Zhenghong","Liang, Junbo","Zhang, Rong","Lin, Xinhua"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303993","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s13238-020-00718-6","topics":["Mechanism"],"weight":1,"_version_":1666138491069661185,"score":52.463547},{"pmid":32339250,"title":"A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019.","text":["A potential ex vivo infection model of human induced pluripotent stem cell-3D organoids beyond coronavirus disease 2019.","The novel coronavirus disease 2019 (COVID-19) outbreak began in the city of Wuhan, whereupon it rapidly spread throughout China and subsequently across the world. Rapid transmission of COVID-19 has caused wide-spread panic. Many established medications have been used to treat the disease symptoms; however, no specific drugs or vaccines have been developed. Organoids derived from human induced pluripotent stem cells (iPSCs) may serve as suitable infection models for ex vivo mimicking of the viral life cycle and drug screening. Human iPSC-3D organoids, self-organised tissues with multiple cell environments, have a similar structure and function as real human organs; hence, these organoids allow greater viral infection efficiency, mimic the natural host-virus interactions, and are suitable for long-term experimentation. Here, we suggest the use of a functional human iPSC-organoid that could act as a reliable and feasible ex vivo infection model for investigation of the virus. This approach will provide much needed insight into the underlying molecular dynamics of COVID-19 for the development of novel treatment and prevention strategies.","Histol Histopathol","Zhou, Hang","Liu, Li-Ping","Fang, Mei","Li, Yu-Mei","Zheng, Yun-Wen","32339250"],"abstract":["The novel coronavirus disease 2019 (COVID-19) outbreak began in the city of Wuhan, whereupon it rapidly spread throughout China and subsequently across the world. Rapid transmission of COVID-19 has caused wide-spread panic. Many established medications have been used to treat the disease symptoms; however, no specific drugs or vaccines have been developed. Organoids derived from human induced pluripotent stem cells (iPSCs) may serve as suitable infection models for ex vivo mimicking of the viral life cycle and drug screening. Human iPSC-3D organoids, self-organised tissues with multiple cell environments, have a similar structure and function as real human organs; hence, these organoids allow greater viral infection efficiency, mimic the natural host-virus interactions, and are suitable for long-term experimentation. Here, we suggest the use of a functional human iPSC-organoid that could act as a reliable and feasible ex vivo infection model for investigation of the virus. This approach will provide much needed insight into the underlying molecular dynamics of COVID-19 for the development of novel treatment and prevention strategies."],"journal":"Histol Histopathol","authors":["Zhou, Hang","Liu, Li-Ping","Fang, Mei","Li, Yu-Mei","Zheng, Yun-Wen"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339250","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.14670/HH-18-223","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138494203854848,"score":47.522205}]}